Breaking News Instant updates and real-time market news.

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27

Medtronic shares 'could rise even more,' Barron's says

Barron's recommended Medtronic (MDT) just over two years ago, and Barron's Jack Hough said it still looks attractive, at 19 times forward earnings estimates, with a 2% dividend. Additionally, newly published study results suggest that Medtronic's Micra could treat a dual-chamber condition called atrioventricular block in addition to a single heart chamber, and the company is applying for expanded approval. This could give the device "another 40% of the market," Hough believes, adding that Medtronic could launch a dual-chamber device as soon as early next year. Reference Link

  • 19

    Nov

MDT Medtronic
$112.11

2.9 (2.66%)

09/25/19
GUGG
09/25/19
NO CHANGE
GUGG
Neutral
Medtronic financial projections for Hugo robot 'underwhelming,' says Guggenheim
After attending Medtronic's (MDT) "much-anticipated" robotic-assisted surgery event, where the company gave a first look at the Hugo RAS system, Guggenheim analyst Chris Pasquale noted that the company gave an update on regulatory timelines and initial revenue targets, though information on pricing and clinical comparability to Intuitive Surgical's (ISRG) da Vinci system were "notably absent." He was impressed by certain design elements, though he thinks management's financial projections for Hugo were "somewhat underwhelming," said Pasquale, who keeps a Neutral rating on Medtronic shares.
09/27/19
PIPR
09/27/19
NO CHANGE
PIPR
Piper says insulin pump survey most positive for Insulet
Piper Jaffray analyst JP McKim conducted an insulin delivery survey in August and found that pump penetration is going "much higher" both in type 1s and in type 2s. The growth in the type 2 market is underappreciated by investors and will largely benefit Insulet (PODD) today given the pharmacy channel increases that access, McKim tells investors in a research note. Further, survey indicated that Medtronic (MDT) is expected to lose between 1,100-1,300 basis points of market share with Tandem Diabetes (TNDM) being the greatest beneficiary with the biggest uptick forecast in 2020, says the analyst. McKim views the insulin pump survey as most positive for Insulet.
11/01/19
PIPR
11/01/19
INITIATION
Target $39
PIPR
Overweight
Axonics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Adam Maeder initiated coverage of Axonics Modulation Technologies (AXNX) with an Overweight rating and $39 price target. Although there is some investor disappointment that U.S. launch didn't commence sooner and urinary approval is still pending, Axonics remains positioned for commercial success and "strong" sales growth next year, Maeder tells investors in a research note. He believes the company's r-SNM has meaningful advantages over Medtronic's (MDT) InterStim II product and sees "plenty of room in the market for a second competitor."
11/05/19
PIPR
11/05/19
NO CHANGE
PIPR
Overweight
Medtronic filed patent lawsuit against Axonics, says Piper Jaffray
Piper Jaffray analyst Adam Maeder says Medtronic (MDT) yesterday filed a lawsuit with the U.S. District Court for the Central District of California alleging that Axonics Modulation Technologies' rechargeable sacral neuromodulation system infringes its U.S. patents. As part of the lawsuit, Medtronic is seeking injunctive relief and damages for alleged intellectual property infringement, the analyst points out. The timing of the lawsuit coincides with Axonics' U.S. commercial launch, says Maeder, who points out that patent litigation is not uncommon in the medical device sector and generally takes a while to play out. He expects Axonics to "defend itself vigorously and continue to sell r-SNM throughout the ongoing legal process."

TODAY'S FREE FLY STORIES

GME

GameStop

$6.50

0.18 (2.85%)

05:33
12/11/19
12/11
05:33
12/11/19
05:33
Recommendations
GameStop analyst commentary  »

Baird cuts GameStop price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SWAV

ShockWave Medical

$40.43

-0.08 (-0.20%)

05:29
12/11/19
12/11
05:29
12/11/19
05:29
Recommendations
ShockWave Medical analyst commentary  »

ShockWave Medical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOL

Gol Linhas

$16.88

-0.83 (-4.69%)

, DAL

Delta Air Lines

$55.52

-0.27 (-0.48%)

05:26
12/11/19
12/11
05:26
12/11/19
05:26
Hot Stocks
Gol Linhas announces change in shareholding ownership »

GOL Linhas (GOL) hereby…

GOL

Gol Linhas

$16.88

-0.83 (-4.69%)

DAL

Delta Air Lines

$55.52

-0.27 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

JOUT

Johnson Outdoors

$75.16

-2.36 (-3.04%)

05:25
12/11/19
12/11
05:25
12/11/19
05:25
Recommendations
Johnson Outdoors analyst commentary  »

Johnson Outdoors price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$293.21

-9.27 (-3.06%)

05:24
12/11/19
12/11
05:24
12/11/19
05:24
Recommendations
Netflix analyst commentary  »

Piper analysis shows Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$44.26

2.3 (5.48%)

05:20
12/11/19
12/11
05:20
12/11/19
05:20
Recommendations
Agios Pharmaceuticals analyst commentary  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

XBIT

XBiotech

$18.80

-0.65 (-3.34%)

, JNJ

Johnson & Johnson

$139.97

-0.54 (-0.38%)

05:15
12/11/19
12/11
05:15
12/11/19
05:15
Recommendations
XBiotech, Johnson & Johnson analyst commentary  »

XBiotech price target…

XBIT

XBiotech

$18.80

-0.65 (-3.34%)

JNJ

Johnson & Johnson

$139.97

-0.54 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TALO

Talos Energy

$25.79

0.41 (1.62%)

05:14
12/11/19
12/11
05:14
12/11/19
05:14
Hot Stocks
Talos Energy announces acquisition of Gulf of Mexico portfolio »

Talos Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCC

Clarivate Analytics

$16.90

-0.17 (-1.00%)

05:12
12/11/19
12/11
05:12
12/11/19
05:12
Initiation
Clarivate Analytics initiated  »

Clarivate Analytics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$13.60

-6.91 (-33.69%)

05:10
12/11/19
12/11
05:10
12/11/19
05:10
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VALE

Vale

$12.30

-0.08 (-0.65%)

05:06
12/11/19
12/11
05:06
12/11/19
05:06
Upgrade
Vale rating change  »

Vale upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$19.09

0.24 (1.27%)

05:05
12/11/19
12/11
05:05
12/11/19
05:05
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDGJF

John Wood Group

$0.00

(0.00%)

05:05
12/11/19
12/11
05:05
12/11/19
05:05
Upgrade
John Wood Group rating change  »

John Wood Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$80.98

0.24 (0.30%)

05:01
12/11/19
12/11
05:01
12/11/19
05:01
Initiation
Eversource initiated  »

Eversource initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

AEE

Ameren

$74.58

0.6 (0.81%)

05:01
12/11/19
12/11
05:01
12/11/19
05:01
Initiation
Ameren initiated  »

Ameren initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMK

GenMark

$5.58

-0.04 (-0.71%)

05:00
12/11/19
12/11
05:00
12/11/19
05:00
Downgrade
GenMark rating change  »

GenMark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$57.40

0.08 (0.14%)

04:59
12/11/19
12/11
04:59
12/11/19
04:59
Downgrade
Dentsply Sirona rating change  »

Dentsply Sirona…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBI

Texas Capital

$61.90

-1.55 (-2.44%)

, IBTX

Independent Bank

$59.90

-1.74 (-2.82%)

04:56
12/11/19
12/11
04:56
12/11/19
04:56
Upgrade
Texas Capital, Independent Bank rating change  »

Texas Capital upgraded to…

TCBI

Texas Capital

$61.90

-1.55 (-2.44%)

IBTX

Independent Bank

$59.90

-1.74 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Adam…

QMCO

Quantum

$0.00

(0.00%)

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
Quantum management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TCBK

TriCo Bancshares

$39.02

0.24 (0.62%)

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
TriCo Bancshares management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

DMTK

DermTech

$12.90

-1.56 (-10.79%)

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
DermTech management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
Oppenheimer healthcare analysts to hold a KOL dinner meeting »

Analysts hold a Cardiac…

MIC

Macquarie Infrastructure

$42.82

-0.02 (-0.05%)

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
Macquarie Infrastructure management to meet with Suntrust »

Group Dinner with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

04:55
12/11/19
12/11
04:55
12/11/19
04:55
Conference/Events
BTIG oil and tanker analysts to hold a roundtable »

Oil Flow & Tanker…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.